Skip to main content
Close Search
BIVDA NewsletterBIVDA NewsletterBIVDA Newsletter
search
Menu
  • Home
  • Consultations
  • Events Diary
  • Highlights Archive
  • Membership News Archive
  • Regulatory Newsletter
  • Tenders
  • Training
    • In-Person Events
    • Webinars
  • Funding Opportunities
  • Working Party News
    • Working Party Archive
      • AMR Taskforce Archive
      • Covid 19 Taskforce Archive
      • Digital Working Party Archive
      • Environmental Working Party Archive
      • European Affairs Archive
      • Export Working Party Archive
      • External Affairs Working Party
      • Genomics Working Party Archive
      • Market Dynamics Archive
      • Near Patient Testing Working Party Archive
      • Regulatory Affairs Working Party Archive
      • Infectious Diseases Working Party Archive
      • Procurement Working Party Archive
  • search
Category

MedTech Europe Updates Environmental Newsletter

For review by 5 November: Weekly ECHA Substance Evaluations Environmental NewsletterEnvironmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

For review by 5 November: Weekly ECHA Substance Evaluations

Dear Members , MedTech Europe chemicals update. Let me know if the below update impacts you, so we can monitor accordingly. With this email, we would like to inform you about the latest chemicals developments at ECHA and kindly ask you to indicate if any of the following impacts your company by 5 November. Please note that the substances highlighted…
Ben Kemp
Ben KempOctober 31, 2025
Launch of the EU Critical Chemicals Alliance Environmental NewsletterEnvironmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

Launch of the EU Critical Chemicals Alliance

Dear Members, please see below update from MedTech Europe The European Commission launched the 'EU Critical Chemicals Alliance' (link). Background: The recent EU Chemicals Industry Action Plan released a few months ago, indicated that such a platform would be launched, in order to support the chemical sector in view of the challenges they are facing (e.g. high energy prices, etc.) and…
Ben Kemp
Ben KempOctober 31, 2025
UPDATE: For information: ECHA webinar on PFAS SEAC Consultation Environmental NewsletterEnvironmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

UPDATE: For information: ECHA webinar on PFAS SEAC Consultation

Dear members, please see below update on EU progress with the proposed restriction of PFAS substances. Dear members, We are reaching out to follow up on the email below and provide an update regarding the ECHA webinar on the PFAS SEAC draft opinion consultation, which took place today. The webinar presented information on how to prepare for, and what to…
Ben Kemp
Ben KempOctober 31, 2025
For review by 24 September: Weekly ECHA Substance Evaluations Environmental NewsletterEnvironmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

For review by 24 September: Weekly ECHA Substance Evaluations

Please see MedTech Europe Update below, if your impacted by these changes please let me know at regulatory@bivda.org.uk With this email, we would like to inform you about the latest chemicals developments at ECHA and kindly ask you to indicate if any of the following impacts your company by 24 September. Please note that the substances highlighted in yellow are…
Ben Kemp
Ben KempSeptember 22, 2025
For review: PFAS additional timelines Environmental NewsletterEnvironmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

For review: PFAS additional timelines

Dear members, please see below update regarding the ECHA review PFAS substances. If you wish to provide feedback, please email me at regulatory@bivda.org.uk We are writing to inform you that following today's ECHA PFAS discussion in the Socio-Economic Impact Assessment Committee (SEAC), ECHA has just published a press release outlining the following additional timelines (link): ECHA's RAC/SEAC committees plan to…
Ben Kemp
Ben KempSeptember 22, 2025
For Review by 3 September: Weekly ECHA Substance Evaluations Environmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

For Review by 3 September: Weekly ECHA Substance Evaluations

Dear Members, please see below update from MedTech Europe, let me know at regulatory@bivda.org.uk if any of these impact you. Items highlighted have previously been flagged as chemicals in use by the MD/IVD sector. With this email, we would like to inform you about the latest chemicals developments at ECHA and kindly ask you to indicate if any of the…
Ben Kemp
Ben KempAugust 28, 2025
Important: ECHA PFAS Updates Environmental NewsletterEnvironmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

Important: ECHA PFAS Updates

We are writing to inform you that ECHA has just published a press release outlining further insights into the timelines for the adoption of the ECHA RAC & SEAC Opinion on the PFAS Restriction proposal (link).   The press release states that the ECHA RAC & SEAC opinion will most likely be adopted towards the end of 2026. This is…
Ben Kemp
Ben KempAugust 28, 2025
For information: Weekly ECHA Substance Evaluations Environmental NewsletterEnvironmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

For information: Weekly ECHA Substance Evaluations

Dear members, please see below update on the weekly ECHA bulletin. If your impacted by the issues below, let me know at regulatory@bivda.org.uk With this email, we would like to inform you about the latest chemicals developments at ECHA: Publication of the Assessment of Regulatory Needs reports for the following substance groups: Aliphatic esters from branched carboxylic acids and branched…
Ben Kemp
Ben KempAugust 22, 2025
For review: EU Restrictions Roadmap – Revised June 2025 Environmental NewsletterEnvironmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

For review: EU Restrictions Roadmap – Revised June 2025

Please see the below MedTech Europe Update on ECHA’s proposed Restriction roadmap. Note that this will impact products placed on the EU and Northern Ireland markets. If you impacted by the proposals to restrict use of these chemicals, please let me know via regulatory@bivda.org.uk As previously discussed evidence of the impact and lack of available alternatives has been key in…
Ben Kemp
Ben KempAugust 21, 2025
For information: Lead value chain support on Lead Metal CLP Classification Environmental NewsletterEnvironmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

For information: Lead value chain support on Lead Metal CLP Classification

Please see below update from MedTech Europe on the harmonised Classification and labelling of Lead. If you use Lead metal or Lead powder or associated substances please find the below information that applies to products placed on the EU and NI markets. We would like to share a recent communication from the Lead manufacturers (International Lead Association), which aims to…
Ben Kemp
Ben KempAugust 21, 2025
  • Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 9
  • Next

Email us
membership@bivda.org.uk

Call us
+44 (0) 333 3208 823

Website
www.bivda.org.uk

Find us
299 Oxford Street (5th floor)
London, W1C 2DZ

© Copyright 2026 BIVDA Ltd is registered in England, with Company Number 2687137 Registered Office is 299 Oxford Street (5th floor), London, W1C 2DZ. VAT Number 563105858
Web Design by WDAT

  • twitter
  • linkedin
Close Menu
  • Home
  • Consultations
  • Events Diary
  • Highlights Archive
  • Membership News Archive
  • Regulatory Newsletter
  • Tenders
  • Training
    • In-Person Events
    • Webinars
  • Funding Opportunities
  • Working Party News
    • Working Party Archive
      • AMR Taskforce Archive
      • Covid 19 Taskforce Archive
      • Digital Working Party Archive
      • Environmental Working Party Archive
      • European Affairs Archive
      • Export Working Party Archive
      • External Affairs Working Party
      • Genomics Working Party Archive
      • Market Dynamics Archive
      • Near Patient Testing Working Party Archive
      • Regulatory Affairs Working Party Archive
      • Infectious Diseases Working Party Archive
      • Procurement Working Party Archive